RFC1 and polyneuropathy: Of note, since biallelic RFC1 repeat expansions were also identified in 6% of patients who had a presumed secondary cause of DBN, genetic testing might need to be extended to this population as well—especially in the presence of other cerebellar signs, vestibular hypofunction, and/or polyneuropathy—given the implications for clinical management and eligibility for future clinical trials.